Evidence map›Paper›PMID 38131887›Full record

Trial reportCancer medicine2024

Fertility concerns and treatment decision-making among national sample of young women with breast cancer.

Elisabeth de Kermadec, Yue Zheng, Shoshana Rosenberg, Kathryn J Ruddy, Jennifer A Ligibel, Karen M Emmons, Ann H Partridge

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Cancer medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Trial
  2. Young Women Diagnosed With Breast Cancer: Why Is No One Telling Me to Get a Mammogram?Journal of nursing scholarship : an official publication of Sigma Theta Tau International Honor Society of Nursing · 2026
    Article
  3. Article
  4. Childbearing in women diagnosed with cancer during reproductive age.Acta obstetricia et gynecologica Scandinavica · 2025
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Elisabeth de KermadecMedical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Yue ZhengData Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Shoshana RosenbergMedical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Kathryn J RuddyMayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0001-6298-332X
Jennifer A LigibelMedical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Karen M EmmonsHarvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.
Ann H PartridgeMedical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.ORCID 0000-0002-4722-4824
Harvard University · USDana-Farber Cancer Institute · USMayo Clinic · US

Funding

Dissemination Research to Reduce Cancer DisparitiesK05CA124415 · NCI · DANA-FARBER CANCER INST · PI EMMONS, KAREN M. · 2007 to 2011
$810k
Breast Cancer Research FoundationConquer Cancer FoundationNCI NIH HHS K05 CA124415NIH HHS 5K05 CA124415-05Susan G. Komen
6 · The paper itself

Abstract

backgroundDiagnosis of breast cancer in young women has been shown to affect their decision-making with regard to fertility and family planning. Limited data are available from populations across the U.S. regarding this issue; thus, we sought to describe fertility concerns and efforts to preserve fertility in a national clinical trial population of young breast cancer patients.

methodsThe young and strong study was a cluster-randomized controlled trial testing an intervention program for young women with breast cancer. Patients were surveyed within 3 months after diagnosis and at 3, 6, and 12 months after. Surveys asked about sociodemographics, psychosocial domains, fertility concerns, and fertility preservation strategies. Univariable and multivariable models were used to investigate sociodemographic, clinical, and psychosocial predictors of fertility concerns.

resultsOf 467 women from 54 clinical sites across the U.S. (14 academic, 40 community), 419 were evaluable regarding fertility concerns. Median age was 40 years (range 22-45), 11% were Black, 6% Hispanic, and 75% had children. Tumor stage was I (35%), II (51%), or III (14%); 82% received chemotherapy. At time of the treatment decision, 133 (32%) participants had fertility concerns, among whom 47% indicated this affected their treatment decisions. Sixty percent of participants reported having discussed fertility with their physician. Twenty percent of those with fertility concerns used fertility preservation strategies. History of difficulty becoming pregnant and younger age were associated with higher odds of fertility concerns in multivariable modeling.

conclusionMany young women with newly diagnosed breast cancer are concerned about fertility in a way that impacts their treatment decisions. Concerns were discussed, but few used fertility preservation strategies. These findings have implications for counseling young patients.

Indexed as

Breast NeoplasmsDecision MakingFertility PreservationAdultFemaleFertilityHumansMiddle AgedSurveys and QuestionnairesUnited StatesYoung Adultbreast cancerdecision‐makingfertilityfertility concerns and preservation strategiesyoung women

Identifiers

PMID38131887
PMCPMC10807590
OpenAlexW4390114104

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.